These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24513131)

  • 1. Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis.
    Royce SG; Moodley Y; Samuel CS
    Pharmacol Ther; 2014 Mar; 141(3):250-60. PubMed ID: 24513131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease.
    Royce SG; Sedjahtera A; Samuel CS; Tang ML
    Clin Sci (Lond); 2013 Jan; 124(1):41-51. PubMed ID: 22817662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond TGFβ--novel ways to target airway and parenchymal fibrosis.
    Boorsma CE; Dekkers BG; van Dijk EM; Kumawat K; Richardson J; Burgess JK; John AE
    Pulm Pharmacol Ther; 2014 Dec; 29(2):166-80. PubMed ID: 25197006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.
    Royce SG; Lim CX; Patel KP; Wang B; Samuel CS; Tang ML
    Clin Exp Allergy; 2014 Nov; 44(11):1399-408. PubMed ID: 25113628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease.
    Royce SG; Patel KP; Mao W; Zhu D; Lim R; Samuel CS
    Br J Pharmacol; 2019 Jul; 176(13):2195-2208. PubMed ID: 30883698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?
    Roth M
    Drugs; 2015 Jan; 75(1):1-8. PubMed ID: 25414120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis airway epithelium remodelling: involvement of inflammation.
    Adam D; Roux-Delrieu J; Luczka E; Bonnomet A; Lesage J; Mérol JC; Polette M; Abély M; Coraux C
    J Pathol; 2015 Feb; 235(3):408-19. PubMed ID: 25348090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of pulmonary inflammation by mesenchymal cells.
    Alkhouri H; Poppinga WJ; Tania NP; Ammit A; Schuliga M
    Pulm Pharmacol Ther; 2014 Dec; 29(2):156-65. PubMed ID: 24657485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of relaxin in regulation of fibrosis in the lung.
    Tang ML; Samuel CS; Royce SG
    Ann N Y Acad Sci; 2009 Apr; 1160():342-7. PubMed ID: 19416216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway remodelling in asthma: current understanding and implications for future therapies.
    Tang ML; Wilson JW; Stewart AG; Royce SG
    Pharmacol Ther; 2006 Nov; 112(2):474-88. PubMed ID: 16759709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice.
    Maron-Gutierrez T; Silva JD; Asensi KD; Bakker-Abreu I; Shan Y; Diaz BL; Goldenberg RC; Mei SH; Stewart DJ; Morales MM; Rocco PR; Dos Santos CC
    Crit Care Med; 2013 Nov; 41(11):e319-33. PubMed ID: 23760104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological airway remodelling in inflammation.
    Westergren-Thorsson G; Larsen K; Nihlberg K; Andersson-Sjöland A; Hallgren O; Marko-Varga G; Bjermer L
    Clin Respir J; 2010 May; 4 Suppl 1():1-8. PubMed ID: 20500603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic strategies for fibrotic lung disease: a review with a focus on epithelial-mesenchymal transition.
    Noguchi S; Yamauchi Y; Takizawa H
    Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):9-18. PubMed ID: 24383438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.
    Shimizu K; Konno S; Ozaki M; Umezawa K; Yamashita K; Todo S; Nishimura M
    Clin Exp Allergy; 2012 Aug; 42(8):1273-81. PubMed ID: 22805475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic insights into the contribution of epithelial damage to airway remodeling. Novel therapeutic targets for asthma.
    Royce SG; Li X; Tortorella S; Goodings L; Chow BS; Giraud AS; Tang ML; Samuel CS
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):180-92. PubMed ID: 23980699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The footprint of TGF-β in airway remodeling of the mustard lung.
    Shahriary A; Seyedzadeh MH; Ahmadi A; Salimian J
    Inhal Toxicol; 2015; 27(14):745-53. PubMed ID: 26606948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of fibrosis in airway remodeling in asthma.
    Royce SG; Cheng V; Samuel CS; Tang ML
    Mol Cell Endocrinol; 2012 Apr; 351(2):167-75. PubMed ID: 22266540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
    Mottais A; Riberi L; Falco A; Soccal S; Gohy S; De Rose V
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.
    Sohal SS; Ward C; Danial W; Wood-Baker R; Walters EH
    Expert Rev Respir Med; 2013 Jun; 7(3):275-88. PubMed ID: 23734649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of H2 relaxin on airway remodeling and expression of cyclin D1 in a murine model of chronic asthma].
    Han SG; Lü BL; Ding XJ; Zhang J; Huang M
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):349-54. PubMed ID: 22883994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.